ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
96.082,57
-1,16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Europa
  5. EU

  6. Prosus NV (PRX) Börsenkurse

Prosus NV

Prosus NV (PRX)

Prodigy Gold NL
39,865
0,155
(0,39%)
Geschlossen 22 Dezember 5:30PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
39,865
Gebot
39,15
Fragen
40,00
Volumen
9.709.250
39,195 Tagesbereich 40,13
23,755 52-Wochen-Bereich 41,78
Marktkapitalisierung
114,394B
Handelsende
39,71
Handelsbeginn
40,00
Letzte Trade
4173
@
39.865
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
3.051.096
Ausgegebene Aktien
2.869.538.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
17,31
Gewinn pro Aktie (EPS)
2,3
Erlöse
6,22B
Nettogewinn
6,61B

Über Prosus NV

Sektor
Internet Service Provider
Branche
Internet Service Provider
Website
www.prosus.com
Hauptsitz
Amsterdam, North Holland, Nld
Gegründet
-
Prosus NV is listed in the Internet Service Provider sector of the Euronext with ticker PRX. The last closing price for Prosus NV was 39,71 €. Over the last year, Prosus NV shares have traded in a share price range of 23,755 € to 41,78 €.

Prosus NV currently has 2.869.538.000 shares in issue. The market capitalisation of Prosus NV is 113,95 € billion. Prosus NV has a price to earnings ratio (PE ratio) of 17.31.

PRX Neueste Nachrichten

Weitere Nachrichten

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Wednesday, February...

02 Februar 2010
PR Newswire (US)

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA review WARREN, N.J., Jan. 5 /PRNewswire/ -- MonoSol...

05 Januar 2010
PR Newswire (US)

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

16 November 2009
PR Newswire (US)

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the third...

06 November 2009
PR Newswire (US)

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

10 September 2009
PR Newswire (US)

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the second...

04 August 2009
PR Newswire (US)

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Tuesday, August 4...

15 Juli 2009
PR Newswire (US)

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

WARREN, N.J., April 9 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa...

09 April 2009
PR Newswire (US)

MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

Expects to File NDA with FDA in Early to Mid-2009 WARREN, N.J., Dec. 2 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in...

02 Dezember 2008
PR Newswire (US)

/C O R R E C T I O N -- Par Pharmaceutical Companies, Inc./

In the news release, Patrick G. LePore Elected to Board of Directors of Par Pharmaceutical Companies, Inc., issued earlier today by Par Pharmaceutical Companies, Inc. over PR Newswire, we are...

22 Mai 2006
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.65-1.604344070140.51541.17539.195337314740.15071614DE
42.2656.0239361702137.641.4137.6299442839.50335078DE
121.1352.9305447973138.7341.7837.5305109639.33876573DE
265.5116.038422354834.35541.7829.945280598736.25513368DE
529.7832.507894299530.08541.7823.755293024732.85514098DE
156-28.295-41.512617370968.1679.7523.755259907046.5262296DE
260-25.875-39.35959841865.74109.823.755236184556.35384517DE

PRX - Frequently Asked Questions (FAQ)

What is the current Prosus NV share price?
The current share price of Prosus NV is 39,865 €
How many Prosus NV shares are in issue?
Prosus NV has 2.869.538.000 shares in issue
What is the market cap of Prosus NV?
The market capitalisation of Prosus NV is EUR 113,95B
What is the 1 year trading range for Prosus NV share price?
Prosus NV has traded in the range of 23,755 € to 41,78 € during the past year
What is the PE ratio of Prosus NV?
The price to earnings ratio of Prosus NV is 17,31
What is the cash to sales ratio of Prosus NV?
The cash to sales ratio of Prosus NV is 18,4
What is the reporting currency for Prosus NV?
Prosus NV reports financial results in USD
What is the latest annual turnover for Prosus NV?
The latest annual turnover of Prosus NV is USD 6,22B
What is the latest annual profit for Prosus NV?
The latest annual profit of Prosus NV is USD 6,61B
What is the registered address of Prosus NV?
The registered address for Prosus NV is SYMPHONY OFFICES GUSTAV, MAHLERPLEIN 5, AMSTERDAM, NORTH HOLLAND, 1082 MS
What is the Prosus NV website address?
The website address for Prosus NV is www.prosus.com
Which industry sector does Prosus NV operate in?
Prosus NV operates in the INTERNET SERVICE PROVIDER sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TMBSZTME Pharma NV
0,02 €
(185,71%)
132,5k
MLGEQGentlemen S Equity SA
0,0175 €
(118,75%)
1,14k
ALCYBCybergun
0,0002 €
(100,00%)
17,54M
MLAAHAmatheon Agri Holding NV
0,0185 €
(54,17%)
40,1k
ALARFAdeunis
0,94 €
(28,77%)
5,27k
MLSMLSmalto
0,0125 €
(-37,50%)
2,34k
MLFTIFrance Tourisme Immobilier
0,025 €
(-35,90%)
56,77k
CNVCnova NV
0,209 €
(-19,62%)
26,38k
MLWEAWeaccess Group
0,382 €
(-16,96%)
5,95k
ALEUPEuroplasma
0,0353 €
(-15,95%)
3,16M
ATOAtos SE
0,0021 €
(0,00%)
2,71B
BCPBanco Comercial Portugues SA
0,4493 €
(-0,69%)
66,54M
ALHGLouis Hachette Group
1,3342 €
(4,87%)
52,04M
KPNKoninklijke KPN NV
3,509 €
(-1,21%)
26,9M
VIVVivendi SE
2,51 €
(2,41%)
26,39M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

EU
PRX
Prosus NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten